Serving hundreds of leading biopharmaceutical companies globally:

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 8,206,748

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,206,748

Title:	Powdery composition for nasal administration
Abstract:	A powdery composition for nasal administration, where (1) the composition contains (i) a drug, (ii) a water-absorbing and gel-forming base material such as hydroxypropyl cellulose or hydroxypropylmethyl cellulose and (iii) a water-absorbing and water-insoluble base material such as crystalline cellulose or .alpha.-cellulose, (2) wherein the amount of the water-absorbing and gel-forming base material is about 5-40 wt % based on the total of the water-absorbing and gel-forming base material and the water-absorbing and water-insoluble base material, and (3) wherein the drug is unevenly dispersed more on/in the water-absorbing and water-insoluble base material than on/in the water-absorbing and gel-forming base material.
Inventor(s):	Dohi; Masahiko (Tokyo, JP), Nishibe; Yoshihisa (Tokyo, JP), Makino; Yuji (Tokyo, JP), Fujii; Takao (Tokyo, JP)
Assignee:	Teijin Limited (Osaka, JP)
Application Number:	12/610,901
Patent Claims:	see list of patent claims

Details for Patent 8,206,748

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	➤ Sign Up	Teijin Limited (Osaka, JP)	2016-02-27	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	002	2015-01-23	➤ Sign Up	Teijin Limited (Osaka, JP)	2016-02-27	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	003	2015-01-23	➤ Sign Up	Teijin Limited (Osaka, JP)	2016-02-27	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	004	2015-01-23	➤ Sign Up	Teijin Limited (Osaka, JP)	2016-02-27	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 8,206,748

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
Austria	247456	Sep 15, 2003
Australia	2230297	Sep 16, 1997
Australia	722319	Jul 27, 2000
Canada	2247191	Jan 04, 2005
Canada	2247191	Sep 04, 1997
China	1155368	Jun 30, 2004
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.